Article
Retrospective study on the clinicogenomic characteristics of <i>EGFR</i> mutant and wildtype NSCLC
2020-08-11
Abstract excerpt
<h4>Background</h4> Lung cancer is among the leading causes of mortality. Nearly 90% of all lung cancers are histologically classified as non-small cell lung cancer (NSCLC). A subset of these tumors harbor mutations on the epidermal growth factor receptor gene ( EGFR ) and such patients are candidates for targeted therapy with EGFR tyrosine kinase inhibitors (EGFR TKIs). <h4>Aim</h4> To compare and contrast the cl...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b08b1d80-3eb6-544e-919c-040c6404fc50
- DOI
- 10.1101/2020.08.07.20170027
